Dai-ichi Life Insurance Company’s 10x Genomics TXG Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,413	Closed	-$1.1M	–	518
2022 Q1	$1.1M	Hold	14,413	–	–	0.02%	411
2021 Q4	$2.15M	Buy	14,413 +8,869	+160%	+$1.36M	0.03%	340
2021 Q3	$807K	Buy	+5,544	New	+$952K	0.01%	442

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Dai-ichi Life Insurance Company's TXG Position: Q2 2022 in Review

Dai-ichi Life Insurance Company sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 14,413 shares — an estimated $1.1M sold.

Dai-ichi Life Insurance Company first reported a position in TXG in Q3 2021 and held it in 3 quarters. The position peaked at $2.15M in Q4 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

Dai-ichi Life Insurance Company reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
Dai-ichi Life Insurance Company sold 14,413 10x Genomics shares in Q2 2022, an estimated $1.1M.
Dai-ichi Life Insurance Company first reported a position in 10x Genomics in Q3 2021 and held it in 3 quarters.
Dai-ichi Life Insurance Company's 10x Genomics position peaked at $2.15M in Q4 2021.
254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2022, filed 12 Aug 2022.